People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

23.72USD
21 Aug 2014
Price Change (% chg)

$0.29 (+1.24%)
Prev Close
$23.43
Open
$23.38
Day's High
$23.72
Day's Low
$23.09
Volume
205,044
Avg. Vol
223,099
52-wk High
$28.48
52-wk Low
$17.14

Search Stocks

Kramer, Robert 

Brief Biography

Mr.Robert G. Kramer Sr., is Chief Financial Officer, Interim Executive Vice President - Corporate Services Division, Principal Financial and Accounting Officer, Treasurer of Emergent BioSolutions Inc., effective from December 3, 2012. He is responsible for finance and administration, human resources, IT, investor relations, quality, regulatory affairs and medical affairs. Mr. Kramer first joined Emergent in 1999 as its chief financial officer. From 1999 until his retirement in 2010, he held various executive positions with the last being president of Emergent Biodefense Operations Lansing. Mr. Kramer returned to the company in 2011 as the interim head of the Biosciences division, and then as interim executive vice president, corporate services division before taking his current position. Prior to joining Emergent in 1999, Mr. Kramer held various financial management positions at Pharmacia Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer received an M.B.A. from Western Kentucky University and a B.S. in industrial management from Clemson University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
694,200 -- 106,547 800,747

Options Compensation

  Quantity Market Value
Exercisable 178,500 --
Unexercisable 24,000 --
Exercised 467,528 4,286,840.00
Name Fiscal Year Total

Fuad El-Hibri

1,295,470

Daniel Abdun-Nabi

2,160,850

Robert Kramer

800,747

Anatolio Cruz

--

Adam Havey

805,364

Barry Labinger

138,944
As Of 30 Dec 2013
Search Stocks